Events

Upcoming Events

  2017

April 27, 2017

Alliance for Regenerative Medicine’s 7th Annual Cell & Gene Investor Day – Boston, MA

4DMT presenter: David Kirn, MD — Co-Founder, CEO & Co-Chairman

January 25, 2017

BioSciences Forum – San Francisco, CA

4DMT presenter: David Kirn, MD — Co-Founder, CEO & Co-Chairman

“Engineering Next-Generation Adeno-Associated Viruses for Gene Therapy”

2016

November 29-30, 2016

Piper Jaffray 28th Annual Healthcare Conference – New York, NY

4DMT presenter: David Kirn, MD — Co-Founder, CEO & Co-Chairman

October 5-7, 2016

The Alliance for Regenerative Medicine (ARM) Conference Cell and Gene Meeting on the Mesa – La Jolla, CA

4DMT presenter: David Kirn, MD — Co-Founder, CEO & Co-Chairman

June 23-26, 2016

Choroideremia Research Foundation (CRF) Conference – Philadelphia, PA

4DMT presenter: David Kirn, MD — Co-Founder, CEO & Co-Chairman

“4D Molecular Therapeutics Evolving Gene Therapy”

May 17, 2016

Piper Jaffray GenomeRx Symposium – New York, NY

4DMT presenter: David Kirn, MD — Co-Founder, CEO & Co-Chairman

“Vectors and Promoters Pointing the Way”

2015

October 5-7, 2015

The Alliance for Regenerative Medicine (ARM) Conference Cell and Gene Meeting on the Mesa – La Jolla, CA

4DMT presenter: David Kirn, MD — Co-Founder, CEO & Co-Chairman

“Gene Therapy Vector Evolution: Mixing, Matching, Moving Ahead”

June 13 – 16, 2015

International Conference on Oncolytic Virus Therapeutics, Plenary Session – Boston, MA

4DMT attendee: David Kirn, MD — Co-Founder, CEO & Co-Chairman

June 2, 2015

35th Blankenese Conference, Brain Repair: From Neuroregeneration to Cellular Reprogramming- Hamburg-Blankenese, Germany

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

May 13, 2015

American Society for Gene and Cell Therapy Annual Meeting, Plenary Speaker, Education Session – New Orelans, LA

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

May 13, 2015

Piper Jaffray GenomeRx Symposium – New York, NY

4DMT presenter: David Kirn, MD — Co-Founder, CEO & Co-Chairman

March 25, 2015

Alliance for Regenerative Medicine (ARM) – Annual Investor Day: Panel Speaker, Gene Therapy – New York, NY

4DMT attendee: David Kirn, MD —Co-Founder, CEO & Co-Chairman

March 2-3, 2015

CALBIO Annual Meeting: Panel Speaker, Biotech Entrepreneurship – San Francisco, CA

4DMT attendee: David Kirn, MD — Co-Founder, CEO & Co-Chairman

2014

November 19, 2014

Materials Engineering and Sciences Division Plenary Session, American Institute of Chemical Engineers Annual Conference – Atlanta, GA

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

October 24, 2014

European Society for Gene and Cell Therapy Annual Meeting, Plenary Session – The Hague, The Netherlands

4DMT attendees: David Kirn, MD — Co-Founder,CEO & Co-Chairman, David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

October 24, 2014

National Hemophilia Foundation’s 12th Workshop on New Technologies and Gene Transfer for Hemophilia – Washington, DC

4DMT attendees: Melissa Kotterman, PhD — Director and Head of AAV Research and David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

August 27, 2014

ISAT/DARPA Workshop on Computational Tissue Fabrication – Dedham, MA

4DMT attendee: David Schaffer, PhD – Co-Founder, Acting CSO; Co-Chairman

August 23, 2014

Rejuvenation Biotechnology Conference – Santa Clara, CA

4DMT attendee: David Schaffer, PhD – Co-Founder, Acting CSO; Co-Chairman

August 21, 2014

Gordon Research Conference on Drug Carriers in Medicine & Biology – Waterville Valley, NH

4DMT attendee: David Schaffer, PhD – Co-Founder, Acting CSO; Co-Chairman

July 22, 2014

Swiss Institute of Experimental Cancer Research, Lausanne University, Distinguished Clinician Lectureship – Lausanne, Switzerland

4DMT attendee: David Kirn, MD — Co-Founder, CEO & Co-Chairman

June 18, 2014

Choroideremia Foundation International Symposium – Denver, CO

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

April 23, 2014

Washington University School of Medicine, Probstein Oncology Visiting Lectureship – St. Louis, MO

4DMT attendee: David Kirn, MD — Co-Founder, CEO & Co-Chairman

April 22, 2014

Materials Research Society Annual Meeting – San Francisco, CA

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

April 17, 2014

Stanford University Regenerative Medicine Seminar Series – Palo Alto, CA

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

April 10-13, 2014

International Conference on Oncolytic Virus Therapeutics Plenary Session – Oxford, United Kingdom

4DMT attendee: David Kirn, MD — Co-Founder, CEO & Co-Chairman

April 10, 2014

Gordon Research Conference on Photosensory Receptors Signal Transduction – Lucca (Barga), Italy

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

March 31, 2014

Annual Siebel Stem Cell Institute Symposium – Stanford, CA

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

March 29, 2014

Keynote Invitation Speaker, 2014 Regenerative Medicine Workshop – Hilton Head, SC

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

March 25, 2014

General Biology Seminar Series – Caltech, Pasadena, CA

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

March 18, 2014

Keynote Panel Debate, Fourth International Conference on Stem Cell Engineering – San Diego, CA

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

February 18, 2014

Johns Hopkins University Biomedical Engineering Department Seminar Series – Baltimore, MD

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman

January 8, 2014

Engineering Conference International Scale-Up and Manufacturing of Cell-Based Therapies III – San Diego, CA

4DMT attendee: David Schaffer, PhD — Co-Founder, Acting CSO; Co-Chairman